89 research outputs found
Therapeutic targets and microenvironment in sequential biopsies of classical Hodgkin lymphoma at diagnosis and relapse
Classical Hodgkin lymphoma is dominated by the non-neoplastic microenvironment, while the neoplastic Hodgkin-Reed-Sternberg cells compose only a minority of cells in the lymphoma tissue. Both the Hodgkin-Reed-Sternberg cells due to their expression of CD30 and PD-L1 and the microenvironment with abundant T cells and expression of PD1 are specifically targeted by new treatment concepts. We aimed to understand the dynamics of therapeutic targets in patients treated with conventional chemotherapy. We analyzed sequential biopsy specimens obtained at diagnosis and at relapse from the same patient for morphology, immunophenotype, and microenvironmental components. The morphological subtype changed between primary and relapse biopsy in 20% of cases. The immunophenotype was stable with respect to CD30, CD3, and LMP1 but variable with respect to CD15 and CD20 expression. Gene expression revealed 8 upregulated and 20 downregulated genes at relapse (p <= 0.05) with a consistent logarithmic fold change direction in at least 75% of all cases. For PD1, we found discrepant results between gene expression analysis (decrease at relapse) and number of PD1-positive cells assessed by immunohistochemistry (unchanged at relapse). PD-L1 in the neoplastic cells appeared unchanged between primary diagnosis and relapse. The expression of the therapeutic targets CD30, PD1, and PD-L1 can reliably be assessed in tumor specimen at first diagnosis and is unchanged under conventional chemotherapy
Effectiveness of training general practitioners to improve the implementation of brief stop-smoking advice in German primary care: study protocol of a pragmatic, 2-arm cluster randomised controlled trial (the ABCII trial)
Background: The German clinical guideline on tobacco addiction recommends that general practitioners (GPs)
provide brief stop-smoking advice to their patients according to the “5A” or the much briefer “ABC” method, but its
implementation is insufficient. A lack of training is one barrier for GPs to provide such advice. Moreover, the respective
effectiveness of a 5A or ABC training regarding subsequent delivery of stop-smoking advice has not been investigated.
We developed a training for GPs according to both methods, and conducted a pilot study with process evaluation to
optimize the trainings according to the needs of GPs. This study aims at evaluating the effectiveness of both trainings.
Methods: A pragmatic 2-arm cluster randomised controlled trial with a pre-post data collection will be conducted in
48 GP practices in North Rhine-Westphalia (Germany). GPs will be randomised to receive a 3.5-h-training in delivering
either 5A or ABC, including peer coaching and intensive role plays with professional actors. The patient-reported
primary outcome (receipt of GP advice to quit: yes/no) and secondary outcomes (recommendation rates of smoking
cessation treatments, group comparison (5A versus ABC): receipt of GP advice to quit) will be collected in smoking
patients routinely consulting their GP within 4 weeks prior, and 4 weeks following the training. Additional secondary
outcomes will be collected at 4, 12 and 26 weeks following the consultation: use of cessation treatments during the
last quit attempt (if so) since the GP consultation, and point-prevalence abstinence rates. The primary data analysis will
be conducted using a mixed-effects logistic regression model with random effects for the cluster variable.
Discussion: If the training increases the rates of delivery of stop-smoking advice, it would offer a low-threshold
strategy for the guideline implementation in German primary care. Should one method prove superior, a more specific
guideline recommendation can be propose
Wenn der Zappelphilipp erwachsen ist. Wie können Hausarzt und Psychiater bei ADHS im Erwachsenenalter kooperieren?
- …